BioXcel Therapeutics, Inc. (BTAI) by event type
BTAI moves most on rating reiterations — a median of +0.66% at 30 minutes across 37 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the BTAI overview →
How BTAI reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 477 of 2,603 | 12 | +0.41% | 67% | +1.94% |
| Rating reiterations 98 of 3,522 | 37 | +0.66% | 54% | +1.57% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 4 further classes were observed with fewer than 10 measured events and are not published.
That’s how BTAI usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Rating reiterations → · BTAI overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| OHR PHARMACEUTICALS (OHRP) | 393 | 0.00% | 48% |
| ACADIA Pharmaceuticals Inc. (ACAD) | 392 | -0.14% | 43% |
| Karyopharm Therapeutics Inc. (KPTI) | 392 | -0.45% | 45% |
| Rubius Therapeutics, Inc. (RUBY) | 392 | -0.32% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.